Charles A. Thornton, M.D. University of Rochester
Principal Investigatorwork Box 673 601 Elmwood Ave Rochester NY 14642 office: MC 5-5207 p (585) 275-2542 Charles_Thornton@URMC.ROCHESTER.EDU Research Focus: Neurogenetic disorders, including myotonic dystrophy; therapeutics, including antisense approaches.
Graduate Studentwork Rochester NY Samuel_Carrell@urmc.rochester.edu Research Focus: Molecular biology/neuroscience
Graduate Studentwork Rochester NY email@example.com Research Focus: Understanding the pathogenesis of myotonic dystrophy and developing new therapies
- Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy.Clin Exp Allergy. 45, 844-58. (2015 May 01).
- TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy.Hum Mol Genet. 24, 2035-48. (2015 Apr 01).
- Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.Nucleic Acids Res. 43, 3318-31. (2015 Mar 31).